Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 12

TABLE OF CONTENTS Volume 20, Issue 12 (December 2013) In this issue Editorial Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top The Promised Land R E Sobol and K J Scanlon Cancer Gene Ther 2013 20: 651; 10.1038/cgt.2013.73 Full Text Original Articles Top DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques N Obeng-Adjei, N A Hutnick, J Yan, J S Chu, D J F Myles, M P Morrow, N Y Sardesai and D B Weiner Cancer Gene Ther 2013 20: 652-662; advance online publication, December 6, 2013; 10.1038/cgt.2013.65 Abstract | Full Text Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma Z Zhang, K Kawamura, Y Jiang, M Shingyoji, G Ma, Q Li, J Hu, Y Qi, H Liu, F Zhang, S Kang, B Shan, S Wang, S Chada and M Tagawa Cancer Gene Ther 2013 20: 663-670; advance online publication, November 22, 2013; 10.1038/cgt.2013.66 Abstract | Full Text Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus S Kubo, M Takagi-Kimura, C R Logg and N Kasahara Cancer Gene Ther 2013 20: 671-677; advance online publication, November 8, 2013; 10.1038/cgt.2013.67 Abstract | Full Text Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases S H Hong, H J Lee, J An, I Lim, C Borlongan, K S Aboody and S U Kim Cancer Gene Ther 2013 20: 678-682; advance online publication, December 6, 2013; 10.1038/cgt.2013.69 Abstract | Full Text Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine C M Jay, C Ruoff, P Kumar, H Maass, B Spanhel, M Miller, A Arrington, N Montalvo, V Gresham, D D Rao, C Evans, Z Wang, F C Brunicardi, S-H Liu, G Zhou, N Senzer, J Nemunaitis, L King, B Weeks, F J Clubb, T W Fossum and P B Maples Cancer Gene Ther 2013 20: 683-689; advance online publication, November 29, 2013; 10.1038/cgt.2013.68 Abstract | Full Text S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression S-Y Xu, F Wang, G Wei, B Wang, J-Y Yang, Y-Z Huang, L Zhang, F Zheng, L-Y Guo, J-N Wang and J-M Tang Cancer Gene Ther 2013 20: 690-694; advance online publication, December 13, 2013; 10.1038/cgt.2013.70 Abstract | Full Text Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas L Heller, V Todorovic and M Cemazar Cancer Gene Ther 2013 20: 695-700; advance online publication, November 29, 2013; 10.1038/cgt.2013.71 Abstract | Full Text Corrigenda Top Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation J Pan, N J S Fauzee, Y-l Wang, Y-T Sheng, Y Tang, J-Q Wang, W-q Wu, J-x Yan and J Xu Cancer Gene Ther 2013 20: 701-702; 10.1038/cgt.2013.75 Full Text Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy S C H Karlsson, A C Lindqvist, M Fransson, G Paul-Wetterberg, B Nilsson, M Essand, K Nilsson, P Frisk, H Jernberg-Wiklund and S I A Loskog Cancer Gene Ther 2013 20: 702; 10.1038/cgt.2013.76 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.